ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q3Scopus Q2SCImago #11,734Gold OA

Journal of Applied Biomedicine

Abbreviation (ISO):J. APPL. BIOMED
•
Identifier (ISSN):1214-021X(Print)/1214-0287(Online)
•
Publisher:Elsevier Espana
Clarivate IF (2026)
1.9↓ -0.1
Journal Impact Factor
IF Trend↓
WoS Quartile
Q3
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2019–2026)

Clarivate IF trend for Journal of Applied Biomedicine

WoS Q3
01231.7820191.5720201.820210.520221.3202322024220251.92026
Annual Impact Factor Metric
Current (2026):1.9
Scopus SJR & RankScopus Q2
0.507
#11,734

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
42

42 papers with at least that number of citations each

WoS: SCIE / JCRQ3
Self-Citation Rate5%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessGold OA
26articles/year
100% Gold OA•94.12% Original Research

Aims & Scope

Journal of Applied Biomedicine promotes translation of basic biomedical research into clinical investigation, conversion of clinical evidence into practice in all medical fields, and publication of new ideas for conquering human health problems across disciplines. Providing a unique perspective, this international journal publishes peer-reviewed original papers and reviews offering a sensible transfer of basic research to applied clinical medicine. Journal of Applied Biomedicine covers the latest developments in various fields of biomedicine with special attention to cardiology and cardiovascular diseases, genetics, immunology, environmental health, toxicology, neurology and oncology as well as multidisciplinary studies. The views of experts on current advances in nanotechnology and molecular/cell biology will be also considered for publication as long as they have a direct clinical impact on human health. The journal does not accept basic science research or research without significant clinical implications. Manuscripts with innovative ideas and approaches that bridge different fields and show clear perspectives for clinical applications are considered with top priority.

Topics Covered (Recognized by AI)
Biology89%Medicine88.3%Chemistry78%Biochemistry60.1%Internal medicine57.7%Genetics55.9%Organic chemistry35.1%Physics34.8%Endocrinology33.2%Pharmacology30.5%Psychology23.2%Cell biology23.1%Pathology22.2%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

MEDICINE, RESEARCH & EXPERIMENTAL

Q3
Rank129/191
IndexSCIE
JCRSCIE2026

PHARMACOLOGY & PHARMACY

Q3
Rank253/356
IndexSCIE
JCISCIE2026

MEDICINE, RESEARCH & EXPERIMENTAL

Q3
Rank120/191
IndexSCIE
JCISCIE2026

PHARMACOLOGY & PHARMACY

Q3
Rank241/356
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF1.9
Articles / Year7
Total Citations0
2025
IF2
Articles / Year19
Total Citations24
2024
IF2
Articles / Year27
Total Citations91
2023
IF1.3
Articles / Year25
Total Citations141
2022
IF0.5
Articles / Year19
Total Citations203

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #11,734Scopus Q2SCImago Profile
Scopus Coverage:2005-2025
Scopus Broad Areas:Agricultural and Biological SciencesBiochemistry, Genetics and Molecular BiologyComputer ScienceEngineeringEnvironmental ScienceImmunology and MicrobiologyMedicineNeurosciencePharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q2
0.507

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
1.96

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,765 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations156
3-Year Documents71
Citable Documents71

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate42.4%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Agricultural and Biological Sciences (miscellaneous)Q2
Artificial IntelligenceQ2
Biochemistry, Genetics and Molecular Biology (miscellaneous)Q2
Immunology and Microbiology (miscellaneous)Q2
Pharmacology, Toxicology and Pharmaceutics (miscellaneous)Q2
Biomedical EngineeringQ3
Health, Toxicology and MutagenesisQ3
Medicine (miscellaneous)Q3
Neuroscience (miscellaneous)Q3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 5%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区MEDICINE, RESEARCH & EXPERIMENTAL
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Journal of Applied Biomedicine (abbr: J. APPL. BIOMED, ISSN: 1214-021X) is a peer-reviewed international scholarly journal in the field of PHARMACOLOGY & PHARMACY, published by Elsevier Espana in Czech Republic since 2003. The periodical holds a Journal Impact Factor (JIF) of 1.90, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.507 (Q2), an H-index of 42.

The journal enforces rigorous peer evaluation with a publication frequency of Quarterly, an annual output of approximately 26 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $2,765 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Gold OA
Publisher
Elsevier Espana
Publication Language
English
Frequency
Quarterly
Founding Year
2003
Indexing & Databases
SCIEScopusDOAJPubMed
Editorial Address
UNIV SOUTH BOHEMIA, FAC HEALTH & SOCIAL STUD, JIROVCOVA, CESKA BUDEJOVICE, CZECH REPUBLIC, 37004

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: c76a2d4c-5587-4b61-bf8e-4c375865d876
Database Updated: 2026-10-01